Redeye endorses today’s news that Acarix has secured a fixed reimbursement of USD300 for the CADScor System. This represents a key milestone in the company’s US commercialisation efforts. Furthermore, we anticipate a potential snowball effect could follow, with additional private payors likely also to provide fixed reimbursement in the near future.
LÄS MER